Skip to content

Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.

Computerized Working Memory Training in Adults With Substance Abuse and Executive Function Deficits: A Randomised Controlled Trial.

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02068261
Enrollment
100
Registered
2014-02-21
Start date
2014-01-31
Completion date
2016-12-31
Last updated
2015-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antisocial Personality, Anxiety, Depression, Executive Dysfunction, Reading Disabilities, Substance Abuse

Brief summary

The purpose of this study is to evaluate the effects of a computerized working memory training program on substance abuse, psychosocial functioning, cognitive performance and psychiatric problems in adults with substance abuse and attention problems.

Detailed description

The primary aim of this study is to examine the effects of 5 weeks of computerized working memory training on substance abuse. Secondary aims are to explore whether effects are mediated by changes in executive functions and/or moderated by personality. Also, effects on measures of psychosocial functioning, depression, anxiety and attention will be explored. Follow-up assessment will be conducted at 6 months post training.

Interventions

BEHAVIORALComputerized Cogmed working memory training

Computerized working memory training with Cogmed QM software. The QM software consists of a set of verbal and visual working memory tasks which is trained for 25-40 minutes each session.

BEHAVIORALTreatment as usual

Treatment as usual can consist of medication, psychotherapy, counseling, and psychological assessment.

Sponsors

Örebro Läns Landsting
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Treatment seeking adults with substance abuse and executive function deficits.

Exclusion criteria

* Acute intoxication or abstinence symptoms of any substance. * Psychosis.

Design outcomes

Primary

MeasureTime frame
Change from baseline in substance abuse measured with Substance abuse scales in Adult Self Report (ASR; ASEBA).Baseline and at 25 weeks

Secondary

MeasureTime frame
Change from baseline in Adult Self Report (ASR; ASEBA) Internalizing index.Baseline and at 25 weeks
Change from baseline in Adult Self Report (ASR; ASEBA) Externalizing index.Baseline and at 25 weeks
Change from baseline in Adult Self Report (ASR; ASEBA) Adaptive functioning scales.Baseline and at 25 weeks
Change from baseline in Executive functioning measured with Behavior Rating Inventory of Executive Function-Adult (BRIEF-A).Baseline and at 25 weeks
Change from baseline in Adult Self Report (ASR; ASEBA) Attention problems scale.Baseline and at 25 weeks
Change from baseline in visual working memory measured with performance on Span board.Baseline and at 25 weeks
Change from baseline in focused attention measured with performance on Conners Continuous Performance Test-II (CCPT-II).Baseline and at 25 weeks
Change from baseline in vigilance measured with performance on Conners Continuous Performance Test-II (CCPT-II).Baseline and at 25 weeks
Change from baseline in reading speed measured with performance on Reading speed in Diagnostic Reading and Writing Test (DLS; Swedish version).Baseline and at 25 weeks
Change from baseline in verbal working memory measured with performance on Digit span.Baseline and at 25 weeks

Countries

Sweden

Contacts

Primary ContactRickard Ahlberg, doctoral student
rickard.ahlberg@orebroll.se
Backup ContactKurt Skårberg, MD
kurt.skarberg@orebroll.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026